Beyond Formulation: Contributions of Nanotechnology for Translation of Anticancer Natural Products into New Drugs.

Miguel, Rodrigo Dos A; Hirata, Amanda S; Jimenez, Paula C; Lopes, Luciana B; Costa-Lotufo, Leticia V

Miguel, Rodrigo Dos A; Hirata, Amanda S; Jimenez, Paula C; Lopes, Luciana B; Costa-Lotufo, Leticia V.

Afiliação

Miguel RDA; Institute of Biomedical Sciences, University of Sao Paulo, Sao Paulo 05508-000, Brazil.
Hirata AS; Institute of Biomedical Sciences, University of Sao Paulo, Sao Paulo 05508-000, Brazil.
Jimenez PC; Institute of the Sea, Federal University of Sao Paulo, Santos 11070-100, Brazil.
Lopes LB; Institute of Biomedical Sciences, University of Sao Paulo, Sao Paulo 05508-000, Brazil.
Costa-Lotufo LV; Institute of Biomedical Sciences, University of Sao Paulo, Sao Paulo 05508-000, Brazil.

Pharmaceutics ; 14(8)2022 Aug 17.

Article em En | MEDLINE | ID: mdl-36015347

Palavras-chave

anticancer drugs; doxorubicin; drug delivery; nanotechnology; natural products; paclitaxel

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Pharmaceutics Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Brasil País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google